Bajaj Healthcare Limited (BAJAJHCARE) Financial Results — Revenue ₹16,644.31 Cr

Investor Takeaways

Reported 69.9% YoY revenue growth to ₹16,644.31 Cr, driven by operational performance

Net profit turned negative at ₹1,369.80 Cr due to exceptional items and revenue reversals

Board retained Mr. Gopalakrishnan Kesavan as Non-Executive Independent Director until 2030

Auditor issued unmodified limited review conclusion with no material misstatements identified

⚠️ Net loss of ₹1,369.80 Cr reflects significant profitability pressure despite revenue growth

Overall Tone: Cautious

Key Financial Highlights

Metric	Value	YoY Change
Revenue	₹16,644.31 Cr	69.9%
Net Profit	₹1,369.80 Cr	Negative
EBITDA	Not available	N/A
EPS	Not available	N/A
OPM	Not available	N/A

What Changed

Bajaj Healthcare Limited reported a 69.9% year-on-year increase in revenue to ₹16,644.31 Cr for Q1 FY26, primarily attributed to strong operational performance. However, the company recorded a net loss of ₹1,369.80 Cr, driven by exceptional items and the reversal of ₹3,324.66 lakhs of prior-year revenue recognition amid Middle East instability. The board retained Mr. Gopalakrishnan Kesavan as Non-Executive Independent Director until 2030, pending shareholder approval. The auditor issued an unmodified limited review conclusion, confirming no material misstatements in the financials. The company utilized funds for loan repayment and capital expenditure, though specific utilization details were not elaborated.

Peer Comparison

Company	P/E	ROE	ROCE	Market Cap (₹ Cr)
Bajaj Healthcare	44.89	Not available	Not available	956.52
Sun Pharmaceutical Industries Limited	41.28	15.11%	20.34%	4,50,643.09
Divi's Laboratories Limited	72.41	16.56%	22.09%	1,79,470.03
Torrent Pharmaceuticals Limited	80.06	N/A	N/A	1,49,108.91

Bajaj Healthcare’s P/E ratio of 44.89 is lower than Divi's Laboratories (72.41) and Torrent Pharmaceuticals (80.06), but higher than Sun Pharmaceutical (41.28). The company’s market capitalization is significantly smaller than its peers, indicating a more niche market presence.

Risks & Concerns

Net loss of ₹1,369.80 Cr raises concerns about profitability sustainability

Revenue growth driven by operational performance, but offset by exceptional items and revenue reversals

Reliance on one-time adjustments for financial results increases execution risk

Limited transparency on fund utilization for loan repayment and capex

Auditor’s limited review may not cover all material aspects of financial statements

Quarterly Trend

[Not available]

CRITICAL: Quarterly trend data was not provided in the context. The Quarterly Trend section has been omitted per instructions.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BAJAJHCARE ✨ Ask AI About This

About Bajaj Healthcare Limited (BAJAJHCARE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹956.52 Cr P/E: 44.9

View full BAJAJHCARE stock details →

📡 Get AI alerts when BAJAJHCARE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BAJAJHCARE — Free

💡 Ask AI about this filing

"How will the company address the Rs. 3,324.66 lakhs revenue reversal impact on future profitability?" "What is the expected timeline for NCLT approval to consolidate Genrx Pharmaceuticals into financials?" "How does the 69.9% revenue growth compare to peers in the pharmaceutical segment?"

Ask AI Free →

📊 More BAJAJHCARE filings

See all BAJAJHCARE filings →

🔥 Also filed on 20 July 2026

ANDHRAPAP ANDHRA PAPER LIMITED Annual Report CANHLIFE Canara HSBC Life Insurance Company Limited Financial Results CANBK Canara Bank Corporate Action KROSS Kross Limited Financial Results IDFCFIRSTB IDFC First Bank Limited Financial Results J&KBANK The Jammu & Kashmir Bank Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when BAJAJHCARE files new disclosures

Track BAJAJHCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.